Clay Siegall is the co-founder, CEO, and Chairman of the Seattle Genetics. He founded this company in 1998 on a foundation of scientific innovation, research, and drug development. The company was also coupled with a passion for helping patients. Clay’s aim of the company was to help cancer patients in particular. The company is currently one of the leading in the development of antibody drugs the ADCs. In 2011, the company received approval for the production of its first ADC. Clay is advancing in the production of ACDs for the treatment of cancer.
Dr. Clay Siegall has been having several posts about various scientific discoveries. There was a post on his official blog about a man who was paralyzed on the one hand. The man decoded his thought using a system and then controlled his muscles with the system. Surprisingly, the man was able to use his arm again. At the same time, Dr. Siegall posted another post saying that scientists are now able to imitate the reproductive system cycle of women by use of a device. There are many other amazing posts that you will find on this page mostly about scientific discoveries.
Dr. Siegall studied at the Washington University where he earned a doctorate in genetics. He had earlier received a bachelor’s degree in zoology. His continuous research combined with his two degrees have seen Dr. Clay contribute a lot in the world of cancer research. Dr. Siegall joined the board of directors of MirnaTherapeutics in the year 2013. Due to his experience in research, Dr. Clay has held many other portfolios. Some include being a member of the National Cancer Institute.
In an interview with Ideamensch in April 14th, 2017, Dr. Clay discloses that there is one strategy that has helped his organization to grow. That is to work in close collaboration with other industry leaders and innovators on oncology drug development. He says that collaboration has seen the different companies place resources in technology and new ideas all geared towards helping patients. He further disclosed that his idea of dealing with cancer was generated by the fact that at the age of 19, he watched his father troubled by cancer till he met his death.